Xie Y - Search Results

1

Inhibition of N-linked glycosylation down-regulates insulin-like growth factor-1 receptor at the cell surface and kills Ewing's sarcoma cells: therapeutic implications.

Girnita L, Wang M, Xie Y, Nilsson G, Dricu A, Wejde J, Larsson O. Girnita L, et al. Among authors: xie y. Anticancer Drug Des. 2000 Feb;15(1):67-72. Anticancer Drug Des. 2000. PMID: 10888037

2

Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.

Wang M, Xie Y, Girnita L, Nilsson G, Dricu A, Wejde J, Larsson O. Wang M, et al. Among authors: xie y. Exp Cell Res. 1999 Jan 10;246(1):38-46. doi: 10.1006/excr.1998.4280. Exp Cell Res. 1999. PMID: 9882513

3

A novel fusion gene, SYT-SSX4, in synovial sarcoma.

Skytting B, Nilsson G, Brodin B, Xie Y, Lundeberg J, Uhlén M, Larsson O. Skytting B, et al. Among authors: xie y. J Natl Cancer Inst. 1999 Jun 2;91(11):974-5. doi: 10.1093/jnci/91.11.974. J Natl Cancer Inst. 1999. PMID: 10359553 No abstract available.

4

The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.

Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Mandahl N, Lundeberg J, Uhlén M, Larsson O. Nilsson G, et al. Among authors: xie y. Cancer Res. 1999 Jul 1;59(13):3180-4. Cancer Res. 1999. PMID: 10397263

5

Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype.

Xie Y, Skytting B, Nilsson G, Brodin B, Larsson O. Xie Y, et al. Cancer Res. 1999 Aug 1;59(15):3588-91. Cancer Res. 1999. PMID: 10446966

6

Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact.

Girnita L, Girnita A, Brodin B, Xie Y, Nilsson G, Dricu A, Lundeberg J, Wejde J, Bartolazzi A, Wiman KG, Larsson O. Girnita L, et al. Among authors: xie y. Cancer Res. 2000 Sep 15;60(18):5278-83. Cancer Res. 2000. PMID: 11016658

7

Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression.

Brodin B, Haslam K, Yang K, Bartolazzi A, Xie Y, Starborg M, Lundeberg J, Larsson O. Brodin B, et al. Among authors: xie y. Gene. 2001 May 2;268(1-2):173-82. doi: 10.1016/s0378-1119(01)00412-7. Gene. 2001. PMID: 11368913

8

Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas.

Yang K, Lui WO, Xie Y, Zhang A, Skytting B, Mandahl N, Larsson C, Larsson O. Yang K, et al. Among authors: xie y. Oncogene. 2002 Jun 13;21(26):4181-90. doi: 10.1038/sj.onc.1205569. Oncogene. 2002. PMID: 12037676

9

SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.

Xie Y, Skytting B, Nilsson G, Gasbarri A, Haslam K, Bartolazzi A, Brodin B, Mandahl N, Larsson O. Xie Y, et al. Cancer Res. 2002 Jul 1;62(13):3861-7. Cancer Res. 2002. PMID: 12097301

10

The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery.

Xie Y, Skytting B, Nilsson G, Grimer RJ, Mangham CD, Fisher C, Shipley J, Bjerkehagen B, Myklebost O, Larsson O. Xie Y, et al. Oncogene. 2002 Aug 22;21(37):5791-6. doi: 10.1038/sj.onc.1205700. Oncogene. 2002. PMID: 12173050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,278 results

Search Page

Filters